Navigation Links
Synagis in Medical News

MedImmune Expands Access for Eligible Premature Infants to Receive Synagis(R) at No Cost

....S. Department of Health and Human Services (HHS). synagis is a biologic medicine known as a monoclonal antib...e or medical insurance, may be eligible to receive synagis at no cost. This marks a significant expansion ove... to receive the established preventive benefits of synagis as prescribed by their doctor at no cost to the fa...

MedImmune presents new pharmaco-economic data at AAP regarding infants at high risk for RSV

...nounced results from a recent economic analysis of synagis (palivizumab), a monoclonal antibody (MAb) that is...ion, the analysis evaluated the costs of providing synagis to premature infants, as well as the potential hea...ence is needed to substantiate the linkage between synagis and subsequent reductions in persistent wheezing. ...

MedImmune to present RSV surveillance and cost-effectiveness data at American Academy of Pediatrics

... BACKGROUND: Recent trials have suggested that synagis (palivizumab), a monoclonal antibody (MAb) that is... a cost-effectiveness analysis of prophylaxis with synagis compared with no prophylaxis among preterm infants...ether national guidelines for RSV prophylaxis with synagis are sufficient or whether recommendations should b...
Synagis in Medical Technology

New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants

Prophylaxis with Synagis Decreases Incidence of Recurrent Wheeze by Almost Half ABBOTT PARK, Ill. and GAITHERSBURG, Md., June 29, 2007 /PRNewswire-FirstCall/ -- Abbott and MedImmune today announced results of a new study, published in the July issue of Journal of Pediatrics, showing that treatment...

Study Shows Physician Judgment is Important in Reducing Rate of RSV-Related Hospitalizations Among High-Risk Infants

... held this week in Honolulu, HI. About Synagis synagis (palivizumab) is indicated for the prevention of s...rus (RSV) in children at high risk of RSV disease. synagis is given as a shot, usually in the thigh muscle, e...ach month during the RSV season. The first dose of synagis should be given before RSV season begins. Children...

Phase 3 Data Regarding Anti-RSV Antibody To Be Presented at Pediatric Academic Societies (PAS) Annual Meeting

...lanced between treatment groups. About Synagis synagis (palivizumab) is indicated for the prevention of s...rus (RSV) in children at high risk of RSV disease. synagis is given as a shot, usually in the thigh muscle, e...ach month during the RSV season. The first dose of synagis should be given before RSV season begins. Children...

MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV

...ion, the analysis evaluated the costs of providing synagis to premature infants, as well as the potential hea...ence is needed to substantiate the linkage between synagis and subsequent reductions in persistent wheezing. ...high-risk groups. About Synagis(R) (palivizumab) synagis is the only monoclonal antibody approved by the FD...

MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results

...motavizumab appears to have a similar safety and pharmacokinetic profile to synagis (palivizumab) in infants. Additionally, in early phase studies children tre...In its first pivotal trial, which was a head-to-head comparative trial with synagis (palivizumab), motavizumab met its non-inferiority objective by demonstrati...

MedImmune's Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study

...ve a similar safety and pharmacokinetic profile to synagis in infants. Additionally, in early phase studies c...patient management, its secondary endpoint. About synagis synagis is the only monoclonal antibody approved by the FD...

MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease

...6-percent fewer RSV hospitalizations compared with synagis (p<0.01 for non-inferiority). Additionally, motavi..., compared with 1.9 percent for those who received synagis [RR: 0.740, 95 percent CI: (0.503, 1.083)]. The p-...[related AEs: motavizumab (N=298, 9.0 percent) vs. synagis (N=258, 7.8 percent) p=not significant (NS); disco...
Synagis in Medical Dictionary

Home health

...ess to nearly 500 nurses, therapists, social workers and home health aides, all of whom are dedicated ... Health Ministry. More Information. synagis Home Management Program. Visiting Nurse Association ... Home care provides the comfort and convenience of health ... Sta- home Health &am...
Synagis in Biological Technology

MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease

...tions (RSVH) among this population. The use of synagis has been restricted, however, due to cost conc...Book guidelines recommend RSV prophylaxis with synagis for infants born between 32 and 35 weeks gestation...lant patients). About Synagis(R) (palivizumab) synagis is the only monoclonal antibody approved by the FD...

MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition

...ost-effectiveness analysis of prophylaxis with synagis compared with no prophylaxis among preterm inf...ether national guidelines for RSV prophylaxis with synagis are sufficient or whether recommendations shou...splant patients). About Synagis(R) (palivizumab) synagis is the only monoclonal antibody approved by the FD...
Other Tags
(Date:7/12/2014)... Burn injuries increase in the summer as people gather around ... those most vulnerable to these seasonal fire hazards: children. ... burned by putting their hands on the side of cooking ... at Loyola University Medical Center in Maywood, Ill., said in ... you play with fire, you get burned, is true -- ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 As DePuy ... forward in U.S. courts, Bernstein Liebhard LLP notes the ... ion levels to the failure of metal-on-metal hip replacements. ... of The Journal of Bone & Joint Surgery, looked ... Articular Surface Replacement prostheses at least twelve months earlier. ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 Doylestown Hospital ... a variety of men’s health questions. Paddock tackles ... to men, why women live longer than men, and ... Men's Health Made Simple featured on Doylestown Hospital’s ... a hernia at any age. If you notice pain, ...
(Date:7/12/2014)... Praeclarus Press is excited to offer ... resource for women in need of lactation support. Statistics ... from their children. Today’s mothers receive very clear messages ... often feel unsupported when it comes to balancing working ... insights, and written by Nancy Mohrbacher, an international breastfeeding ...
(Date:7/12/2014)... The largest pure occupational medicine company ... announce that it will be opening its fifth Georgia ... join four Atlanta-based Nova Medical Centers’ locations. The ... Bridge Road, and will be open from 8:30 a.m. ... Nova’s treatment philosophy of rapid return-to-work and decreased treatment ...
Breaking Medicine News(10 mins):Health News:Burn Injuries More Common in Summer 2Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 2Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 3Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 4Health News:Ivyland Medical Center’s Dr. Brad Paddock Offers Tips for Men’s Health 2Health News:Praeclarus Press Announces the Release of Working and Breastfeeding Made Simple by Nancy Mohrbacher, A Much Needed Resource For Today's Working Mothers 2Health News:Nova Medical Centers To Open New Facility in Augusta, Georgia 2
(Date:7/10/2014)... 27, 2014  Pomerantz LLP has filed a ... or the "Company")(NYSE-MKT: PVCT) and certain of its ... District Court, Middle District of Tennessee ... a class consisting of all persons or entities ... December 17, 2013 and May 22, 2014, both ...
(Date:7/10/2014)... July 2, 2014 NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication ... Mr. Gino Pereira was interviewed on July 1 ... Tampa Florida . Mr. Pereira discusses the company,s ... Harris and how the Wocket™ aims to replace a ... Cedric Harris tells Gino he has never ...
(Date:7/10/2014)... -- Fingerprint Cards, (FPC,s) new mobile ... An Asian OEM has selected FPC1021 for a flagship model ... 2014.   FPC is proud to announce this ... date for start of mass production in August 2014. FPC ... for delivery in the first half of July. The OEM ...
Breaking Biology News(10 mins):SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 2Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 3Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 4FPC Wins DW and Initial Ramp Order for FPC1021 Touch Sensor for Flagship Smartphone from Asian OEM 2
Other Contents